Skip to content

Evaluation of a Mandibular Advancement Device in the Treatment of Obstructive Sleep Apnea Syndrome

Prospective Evaluation of Mandibular Advancement by Herbst Device in the Treatment of Moderate Obstructive Sleep Apnea Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00213434
Enrollment
Unknown
Registered
2005-09-21
Start date
2001-11-30
Completion date
2006-06-30
Last updated
2013-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

prospective, randomized, polysomnography, orthodontic appliance, removable

Brief summary

The purpose of this study is to determine if the mandibular advancement by Herbst device is effective in the treatment of moderate obstructive sleep apnea patients.

Interventions

DEVICEHerbst oral appliance

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Moderate sleep apnea syndrome (10 \< Respiratory Disorder Index \< 30) * Body mass index (BMI) \< 35 Kg/m2 * Able to give their informed consent

Exclusion criteria

* Pregnant women * Professional drivers requiring continuous positive airway pressure (CPAP) treatment * Psychiatric disorders, and patients unable to realise to study * Severe respiratory pathology which could interfere with the study * Morpheic epilepsy * Benzodiazepines intake * Chronic nasal obstruction * Ear, nose, and throat (ENT) pathology requiring surgery * Previous uvulopalatoplasty surgery * Temporomandibular joint pathology * Gum disease * Insufficient number of teeth to apply the oral appliance * Mobile teeth

Design outcomes

Primary

MeasureTime frame
Comparison of polysomnographic data after 3 months of treatment by oral appliance in 2 groups: one with Herbst device adjusted in maximal mandibular advancement and a placebo group

Secondary

MeasureTime frame
Efficacy on clinical symptoms
Tolerance of the oral appliance
Identification of predictive factors of efficacy
Feasibility of this therapeutic method

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026